Conversely, PART1 has tumor suppressive function in glioma by sponging miR-190a-3p, leading to upregulation miR-190a-3p target PTEN (a tumor suppressor), which subsequently inactivates the PI3K/AKT pathway in glioma cell lines [30]. The gene discussed is PTEN; the disease is central nervous system cancer.